Literature DB >> 23070628

Lymphocyte subsets in pediatric migraine.

Aron Cseh1, Kristof Mark Farkas, Laszlo Derzbach, Katalin Muller, Barna Vasarhelyi, Balazs Szalay, Andras Treszl, Viktor Farkas.   

Abstract

Aseptic inflammation due to activated immune cells has been implicated in the pathomechanism of migraine. We measured the prevalence of regulatory T cells (Tregs), along with that of CD4(+)/CD8(+) lymphocytes and their Th1/Th2 commitment in pediatric migraine. Children and adolescents suffering from migraine without aura, migraine with aura and hemiplegic migraine ictally (n = 53, 27, and 20, respectively), also interictally (n = 33) were recruited and compared to 24 healthy children. Our results indicated comparable prevalence of Tregs, CD4(+) and Th1/Th2 committed cells. CD8(+) prevalence was lower, and CD4(+)/CD8(+) ratio was higher in ictal phase irrespective of the subtype of migraine. No association between CD8(+) prevalence and gender, body weight, disease onset and attack duration in migraine subtypes was found. CD8(+) prevalence was normal in patients in interictal phase. These results suggest the absence of major systemic alteration of adaptive immunity in children and adolescents suffering from migraine; however, a transient decrease of CD8(+) prevalence during the ictal phase was detected irrespective of the subtype of migraine.

Entities:  

Mesh:

Year:  2012        PMID: 23070628     DOI: 10.1007/s10072-012-1218-3

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  33 in total

Review 1.  The role of mast cells in migraine pathophysiology.

Authors:  Theoharis C Theoharides; Jill Donelan; Kristiana Kandere-Grzybowska; Aphrodite Konstantinidou
Journal:  Brain Res Brain Res Rev       Date:  2005-07

2.  Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model.

Authors:  Hayrunnisa Bolay; Uwe Reuter; Andrew K Dunn; Zhihong Huang; David A Boas; Michael A Moskowitz
Journal:  Nat Med       Date:  2002-02       Impact factor: 53.440

Review 3.  Role of regulatory T cells in human diseases.

Authors:  Talal A Chatila
Journal:  J Allergy Clin Immunol       Date:  2005-11       Impact factor: 10.793

Review 4.  An overview on immune system and migraine.

Authors:  P P Bruno; F Carpino; G Carpino; A Zicari
Journal:  Eur Rev Med Pharmacol Sci       Date:  2007 Jul-Aug       Impact factor: 3.507

5.  Triptan drugs, natural killer cell cytotoxicity, and neutrophils pro-matrix metalloproteinase-9 secretion.

Authors:  Javier Puente; Maria Jaque; Carolina Carrasco; Carlos Cruz; Maria Valenzuela; Marion Wolf; Aron Mosnaim
Journal:  Headache       Date:  2008-05-09       Impact factor: 5.887

6.  Flow cytometric analysis of lymphocyte subsets in migraine patients during and outside of an acute headache attack.

Authors:  A D Mosnaim; H Kulaga; A J Adams; M E Wolf; J Puente; F Freitag; S Diamond
Journal:  Cephalalgia       Date:  1998-05       Impact factor: 6.292

Review 7.  Favorable outcome of early treatment of new onset child and adolescent migraine-implications for disease modification.

Authors:  James A Charles; B L Peterlin; Alan M Rapoport; Steven L Linder; Marielle A Kabbouche; Fred D Sheftell
Journal:  J Headache Pain       Date:  2009-06-09       Impact factor: 7.277

8.  The prevalence of headache and migraine in atopic children: an epidemiological study in general practice.

Authors:  M J Mortimer; J Kay; D J Gawkrodger; A Jaron; D C Barker
Journal:  Headache       Date:  1993-09       Impact factor: 5.887

9.  Quantitative and qualitative modifications of lymphocyte subsets after sublingual administration of isosorbide dinitrate in migraineurs. Preliminary report.

Authors:  F Massari; L D'Andrea; M A Cervo; F P Serra; V Covelli; G A Buscaino
Journal:  Acta Neurol (Napoli)       Date:  1994 Feb-Apr

10.  CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells.

Authors:  Weihong Liu; Amy L Putnam; Zhou Xu-Yu; Gregory L Szot; Michael R Lee; Shirley Zhu; Peter A Gottlieb; Philipp Kapranov; Thomas R Gingeras; Barbara Fazekas de St Groth; Carol Clayberger; David M Soper; Steven F Ziegler; Jeffrey A Bluestone
Journal:  J Exp Med       Date:  2006-07-03       Impact factor: 14.307

View more
  6 in total

1.  Evaluation of immune parameters in chronic migraine with medication overuse.

Authors:  L Grazzi; E Corsini; E Ciusani; S Usai; C Vasco; G Bussone
Journal:  Neurol Sci       Date:  2014-05       Impact factor: 3.307

2.  Baseline immune biomarkers as predictors of MBSR(BC) treatment success in off-treatment breast cancer patients.

Authors:  Richard R Reich; Cecile A Lengacher; Kevin E Kip; Steven C Shivers; Michael J Schell; Melissa M Shelton; Raymond H Widen; Catherine Newton; Michelle K Barta; Carly L Paterson; Jerrica R Farias; Charles E Cox; Thomas W Klein
Journal:  Biol Res Nurs       Date:  2014-01-28       Impact factor: 2.522

Review 3.  Sex and the migraine brain.

Authors:  D Borsook; N Erpelding; A Lebel; C Linnman; R Veggeberg; P E Grant; C Buettner; L Becerra; R Burstein
Journal:  Neurobiol Dis       Date:  2014-03-21       Impact factor: 5.996

4.  The role of the immune system and the biomarker CD3 + CD4 + CD45RA-CD62L- in the pathophysiology of migraine.

Authors:  Zbyšek Pavelek; Ondřej Souček; Jan Krejsek; Lukáš Sobíšek; Blanka Klímová; Jiří Masopust; Kamil Kuča; Martin Vališ
Journal:  Sci Rep       Date:  2020-07-23       Impact factor: 4.379

Review 5.  Toll-like receptors and their role in neuropathic pain and migraine.

Authors:  Xuejiao Liu; Wenping Yang; Chenlu Zhu; Songtang Sun; Shouyi Wu; Longde Wang; Yonggang Wang; Zhaoming Ge
Journal:  Mol Brain       Date:  2022-08-20       Impact factor: 4.399

6.  Association between sequence variations of the Mediterranean fever gene and the risk of migraine: a case-control study.

Authors:  Salih Coşkun; Sefer Varol; Hasan H Özdemir; Sercan Bulut Çelik; Metin Balduz; Mehmet Akif Camkurt; Abdullah Çim; Demet Arslan; Mehmet Uğur Çevik
Journal:  Neuropsychiatr Dis Treat       Date:  2016-08-29       Impact factor: 2.570

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.